FLINT, Mich., May 22, 2017 /PRNewswire/ -- Diplomat Pharmacy,
Inc. (NYSE: DPLO) will be hosting its second Analyst and Investor
Day on Tuesday, June 27, 2017 in
New York City.
The nation's largest independent provider of specialty pharmacy
services will provide industry insight and outline strategies for
how the company will drive long-term growth and shareholder value.
Panel discussions will feature external pharmaceutical
manufacturer, payor, and consultant business partners and Diplomat
executives.
A live audio-only webcast of Diplomat's Analyst and Investor Day
and related presentation materials will be available on the
investor relations section of the company's website at
ir.diplomat.is. Following the event, presentation materials and an
audio file will be archived for 90 days at ir.diplomat.is.
About Diplomat
Diplomat (NYSE: DPLO) is the nation's
largest independent provider of specialty pharmacy services—helping
patients and providers in all 50 states. The company offers
medication management programs for people with complex chronic
diseases and delivers unique solutions for manufacturers,
hospitals, payors, providers, and more. Diplomat opened its doors
in 1975 as a neighborhood pharmacy with one essential tenet: "Take
good care of patients and the rest falls into place." Today, that
tradition continues—always focused on improving patient care and
clinical adherence. For more information,
visit diplomat.is.
INVESTOR CONTACT:
Bob East, Westwicke Partners
443.213.0500 | diplomat@westwicke.com
MEDIA CONTACT:
Jenny Cretu, Diplomat
810.768.9370 | jcretu@diplomat.is
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/diplomat-to-host-analyst-and-investor-day-on-june-27-2017-300461541.html
SOURCE Diplomat Pharmacy, Inc.